UTMB was recognized as a Level 3 Epilepsy Monitoring Center by the National Association of Epilepsy Centers, in validation of its commitment to improving the lives of patients with epilepsy.
A Level 3 certified center provides the basic range of medical, neuro psychological, psychosocial and treatment services needed to treat patients with refractory epilepsy. Third-level centers do not perform resective epilepsy surgery - the most common form of treatment for uncontrolled seizures - but do provide services such as noninvasive evaluations and implantation of the vagus nerve stimulator, a pacemaker-like device that helps regulate electrical signals sent from the brain.
UTMB’s dedicated Epilepsy Monitoring Unit was designed to evaluate, diagnose and treat patients who experience hard-to-treat epileptic seizures. This highly specialized unit offers 24/7 monitoring in order to identify the specific region of the brain in which each patient’s seizures originate and provide the appropriate treatment to reduce or eliminate the episodes. Among the features of the unit is extended video EEG monitoring, a highly effective diagnostic tool used to pinpoint the region of the brain where the patient's seizures originate in order to establish an accurate diagnosis of epilepsy or other form of seizure disorder, which may require different treatments.
“This achievement is a testament to UTMB’s dedicated epilepsy care team and underscores our ability to provide comprehensive care to complex cases of epilepsy,” said Dr. Anish Bhardwaj, chair of Neurology at UTMB.
UTMB’s Department of Neurology also offers specialized centers for Parkinson’s and other movement disorders. Physicians in UTMB’s Department of Neurology are pioneering the use of technologically advanced approaches for diagnosis and treatment, including state-of-the-art surgical interventions and the latest generation of medication therapies. In fact, UTMB is home to is one of only three neuro-ICUs in the Houston area and The Mitchell Center for Neurodegenerative Diseases, dedicated to the continuum of basic science for the discovery, testing, development, and application of new treatments for neurodegenerative disorders.